Navigation Links
Ampersand Acquires Willow Laboratories
Date:11/13/2012

LYNN, Mass., Nov. 13, 2012 /PRNewswire/ -- Willow Laboratories announced today that it has been acquired by Ampersand Capital Partners.  Willow is one of the country's leading clinical and forensic toxicology laboratories providing urine, hair, and saliva testing services to a wide range of healthcare providers including treatment centers, physician practices, and other laboratories.  Using state-of-the-art technology, Willow provides qualitative and quantitative alcohol and drugs-of-abuse test results to aid clients in the diagnosis and treatment of substance abuse.

Gail Marcus has joined Willow as president and chief executive officer.  Ms. Marcus has significant experience building successful healthcare service organizations and was recently CEO of Caris Diagnostics, (now Miraca Life Sciences), a national diagnostic pathology laboratory. 

Ms. Marcus also serves as president and CEO of Calloway Laboratories, which recently signed a definitive agreement to be acquired by Ampersand.  She commented, "I am excited to be working with the Willow and Calloway management teams and look forward to sharing strengths and resources across the companies in order to provide clients the most-complete set of toxicology lab services available in the marketplace."

Jared Bartok, general partner at Ampersand, commented that "Willow is another key piece of our strategy to invest in the multi-billion dollar toxicology lab industry.  With the infusion of additional capital and management resources, Willow is well positioned to capitalize on future growth opportunities in the substance abuse market while implementing a zero tolerance compliance policy." 

About Willow Laboratories 
Willow is a state and federally licensed clinical toxicology lab providing a broad spectrum of testing services for substance abuse rehabilitation providers to aid them in the diagnosis and treatment of drug and alcohol addiction.  Founded in 1995, Willow performs millions of drug tests annually and has clients in 20 states. 

To learn more about Willow, visit www.willowlabs.com

About Ampersand Capital Partners  
Ampersand is a Boston-based private equity firm with a focus on middle market growth equity investments in the Healthcare sector.  Ampersand leverages its unique blend of private equity and operating experience to build value and drive long-term performance alongside its portfolio company management teams.  Ampersand's portfolio has included more than twenty years of successful investments in the specialty laboratory industry.

To learn more about Ampersand, visit www.ampersandcapital.com 


'/>"/>
SOURCE Willow Laboratories
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
2. Marken Acquires European Kit Building Operation From LabCorp Clinical Trials
3. PLZ Aeroscience Acquires Assured Packaging
4. NeuroSigma Subsidiary Acquires Thin-Film Nitinol Fabrication Patent Portfolio
5. PneumRx, Inc. Acquires Key Assets From Broncus
6. FMC Corporation Acquires Phytone, Ltd., a Leading European Natural Colors Business
7. Frazier Healthcare Acquires U.S. Commercial Pharmaceutical Packaging Operations from Catalent Pharma Solutions
8. RoundTable Healthcare Partners Portfolio Company, Renaissance Acquisition Holdings, LLC Acquires DPT Laboratories
9. ERT Acquires invivodata to Establish the Industrys Most Experienced Provider of Clinical Outcome Assessment Solutions
10. Arthritis Associates of South Florida Acquires Access to Patient Health History Faster with Digital Pen Technology from Anoto and NextGen Healthcare
11. AstraZeneca Acquires Neuroscience Assets From Link Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- MedSource announced today that it has selected Datatrial,s ... choice.  This latest decision demonstrates MedSource,s commitment to ... by offering a state-of-the-art electronic data capture (EDC) ... the EDC platform of choice in exchange for ... long been a preferred EDC platform by our ...
(Date:6/23/2016)... , June 23, 2016  In a startling report released ... failing their residents by lacking a comprehensive, proven plan to eliminate ... a definitive ranking of how states are tackling the worst drug ... only four states – Kentucky , ... Vermont . Of the 28 failing states, three – ...
(Date:6/23/2016)... , June 23, 2016 Research and ... News Issue 52" report to their offering. ... influenza treatment creates a favourable commercial environment for MedImmune to ... patient base that will serve to drive considerable growth for ... would serve to cap sales considerably, but development is still ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice ... "Film editors can give their videos a whole new perspective by using the ... of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets to ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
Breaking Medicine News(10 mins):